drugset / Trial / NCT02217670

Comparative Bioavailability Study of Metformin HCl 1000 mg Granules vs Glucophage 1000 mg Film-coated Tablet

NCT02217670 ↗

Phase 1 Withdrawn Disphar International B.V.
RandomizedCrossoverOpen-label

Summary

The main purpose of this study is to assess comparative bioavailability of a test formulation of Metformin HCl 1000 mg granules manufactured by Indeus Life Sciences Pvt. Ltd., Mumbai India (An Affiliate Of Disphar International B.V., The Netherlands) relative to Glucophage 1000 mg film-coated tablets of Merck GmbH, Austria in 54 healthy adult subjects under fed conditions. The second aim is to asses the safety of subjects and to determine other pharmacokinetic data.

Timeline

Start
—
Primary completion
2016-01
Completion
—

Outcome

Outcome not reported

Stopped: “Commercial reasons”

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg Oral

Indications

No indication recorded.